Interestingly, levels of blood secretoneurin were markedly increased in several human neurological disorders, such as ischemic stroke, Alzheimer’s disease and neonatal hypoxic-ischemic brain injury [9, 11, 12]. This evidence concerns the gene SCG2 and early-onset autosomal dominant Alzheimer disease.